期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

支架内血栓形成的相关因素和预防策略 被引量：5

Contributing Factors and Prophylactic Measures of Stent Thrombosis
下载PDF
导出
摘要 目前,冠状动脉内支架植入术是冠心病血运重建的主要方法,支架植入可显著减少靶血管的急性闭塞和再狭窄。虽然支架术后支架内血栓形成少见,但危害极大,临床上可表现为急性心肌梗死或猝死。在药物洗脱支架广泛使用的今天,支架内血栓形成引起了业内人士的高度警惕和重视。现就冠状动脉支架内血栓形成的相关因素及预防策略进行综述。 At present,coronary stent implantation is the main modality of coronary revascularization.Stent implantation can significantly reduce the occurrences of acute target vessel occlusion and restenosis after stenting which is rare but extremely harmful.Drug-eluting stents are widely used nowadays and stent thrombosis requires a high vigilance of clinicians.This article mainly reviews the contributing factors and prophylactic measures of coronary stent thrombosis.
作者 张红雨 郑萍 刘涛文
机构地区 广西省壮族自治区南溪山医院心血管内科 广西省壮族自治区南溪山医院肿瘤内科
出处 《医学综述》 2011年第8期1160-1163,共4页 Medical Recapitulate
关键词 支架内血栓 相关因素 预防策略 Stent thrombosis Contributing factors Prophylactic measures
分类号 R364.15 [医药卫生—病理学]
  • 相关文献

参考文献25

  • 1Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007,115(17):2344-2351.
  • 2Takano M,Yamamoto M,Xie Y,et al.Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary an-gioscopy[J].Heart,2007,93(11):1353-1356.
  • 3Joner M,Finn AV,Farb A,et al.Pathology of drug-eluting stents in humans:delayed healing and late thrombotic risk[J].J Am Coll Cardiol,2006,48(1):193-202.
  • 4Takano M,Ohba T,Inami S,et al.Angioscop ic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation[J].Eur Heart J,2006,27(18):2189-2195.
  • 5Virmani R,Guagliumi G,Farb A,et al.Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent:should we be cautious?[J].Circulation,2004,109(6):701-705.
  • 6Nebeker JR,Virmani R,Bennett CL,et al.Hypersensitivity cases associated with drug-eluting coronary stents:a review of available cases from the Researchon Adverse Drug Events and Reports(RADAR)project[J].J Am Coll Cardiol,2006,47(1):175-181.
  • 7Tsimikas S.Drug-eluting stents and late adverse clinical outcomes lessons learned,lessons awaited[J].J Am Coll Cardiol,2006,47(10):2112-2115.
  • 8Rodriguez AE,Mieres J,Fernandez-Pereira C,et al.Coronary stent thrombosis in the currentdrug-eluting stent era:insights from the ERACI Ⅲ trial[J].J Am Coll Cardiol,2006,47(1):205-207.
  • 9Applegate RJ,Sacrinty MT,Little WC,et al.Incidence of coronary stent thrombosis based on academic research consortium definitions[J].Am J Cardiol,2008,102(6):683-688.
  • 10Moussa I,diMario C,Reimers B,et al.Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation:frequency,predictors and clinical outcome[J].J Am Coll Cardiol,1997,29(1):6-12.

二级参考文献75

  • 1肖乐,时德.腔内预衬在人工血管内皮化中的应用[J].中国修复重建外科杂志,2005,19(4):270-273. 被引量：3
  • 2Saia F, Marzocchi A, Sen'uys PW. Drug-eluting stents. The third revolution in percutaneous coronary intervention [ J ]. Ital Heart J, 2005,6(4) :289-303.
  • 3Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drugeluting stents : an observational study of drug-eluting versus baremetal stents [ J ]. J Am Coll Cardiol, 2006,48 ( 12 ) :2584 -2591.
  • 4Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans : delayed healing and late thrombotic risk [ J ]. J Am Coil Cardio1,2006,48 ( 1 ) : 193-202.
  • 5Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drugeluting stents: report from the meeting of theCirculatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8,2006 [ J]. Circulation ,2007,115 ( 17 ) :2352-2357.
  • 6Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents : a collaborative network meta-analysis[ J]. Lancet,2007,370 (9591) :937-948.
  • 7Shishehbor MH, Goal SS, Kapadia SR, et al. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality [ J]. J Am Coll Cardiol,2008,52 ( 13 ) :1041-1048.
  • 8Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials:a case for standardized definitions [ J ]. Circulation ,2007,115 ( 17 ) :2344-2351.
  • 9Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis:biological mechanisms and clinical implications [ J ]. Circulation,2007,115 (8) : 1051-1058.
  • 10Gurbel PA, DiChiara J, Tantry US. Antiplatelet therapy after implantation of drug-eluting stents : duration, resistance, alternatives, and management of surgical patients [ J ]. Am J Cardiol, 2007,100 (8B) :18M-25M.

共引文献13

同被引文献52

  • 1陈纪林,高润霖,杨跃进,乔树宾,秦学文,姚民,刘海波,徐波,吴永健,袁晋青,陈珏,戴军,尤士杰,马卫华.雷帕霉素和紫杉醇药物洗脱支架治疗冠心病复杂病变的临床近远期疗效比较[J].中华医学杂志,2005,85(31):2183-2186. 被引量：11
  • 2韩雅玲,梁明,荆全民,王守力,马颖艳,栾波.52例冠状动脉支架内血栓形成患者的临床特点及介入治疗[J].中华心血管病杂志,2006,34(11):975-978. 被引量：34
  • 3付乃宽,曹月娟,程爱娟,陈永利,卢凤民,许静.冠状动脉药物洗脱支架内血栓形成的临床分析[J].中华老年心脑血管病杂志,2007,9(7):493-493. 被引量：1
  • 4中华医学会心血管病学分会.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2009,37:2-25.
  • 5Wehinger A. Lipoprotein ( a ) andcoronarythrombosis and restenosis after stent placement [ J ]. J Am Coil Cardiol, 1999,33 ( 4 ) : 1005- 1012.
  • 6Trabattoni D, Fabbiocchi F, Montorsi P, et al. Stent thrombosis after sirolimus-and paclitaxel-eluting stent implantation in daily clinical practice : analysis of a single center registry [ J ]. Catheter Cardiovasc lnterv, 2007,70 ( 3 ) :415-421.
  • 7Leong LC, Sim LS, Lee YS, et al. A prospective study to compare the cliagnostic performance of breast elastography versus conventional breast ultrasound [ J ]. Clin Radio1,2010,65 ( 11 ) : 887-894.
  • 8Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thromosis in humans [ J ]. Circulation, 2003, 108 ( 14 ) : 1701-1706.
  • 9Wang JC, Aucoin Barry D, Manuefian D, et al. Incidence of aspirin nonresponsiveness using the Ultegra rapid platelet function assay-ASA[ J]. Am J Cardiol, 2003, 92 (12) :1492-1494.
  • 10Eikelboom JW, Hankey GJ. Failure of aspirin to prevent atherothrombosis: potential mechanisms and implications for clinical practice [ J]. Am J Cardiovasc Drugs,2004,4( 1 ) :57-67.

引证文献5

二级引证文献12

医学综述
2011年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部